Daniele Cattaneo

19PUBLICATIONS
124CO-AUTHORS
Haematological tumoursCardiovascular medicine and haematology not elsewhere classifiedMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 20, 2026
Impact of cytoreductive therapy in myeloproliferative neoplasm-associated splanchnic vein thrombosis.

|Jul 22, 2026
Diabetic Patients With Newly Diagnosed Chronic Myeloid Leukemia: TKI Choice and Early Adverse Events. A Real-Life Survey Within the Italian Chronic Myeloid Leukemia Network.

|Jun 11, 2026
Clinical and Laboratory Characterization of Acquired Von Willebrand Syndrome.

|May 27, 2026
Assessment of Transitioning from High-Potency to Low-Potency Inhibitors in Chronic Myeloid Leukemia (CML) Patients: The Downgrading-Impact (D-IMPACT) Project.

|Feb 13, 2026
Survival and quality-of-life implications of cytopenia trajectories in ruxolitinib-treated myelofibrosis.

Francesca Palandri, Giovanni Caocci, Elisabetta Abruzzese

|Jan 21, 2026
Second attempt to discontinue TKI after molecular relapse in patients with chronic myeloid leukemia: A real-life Italian multicenter study.

Alessandra Iurlo, Daniele Cattaneo, Carmen Fava

Pageof 4

Frequent Collaborators

15 joint publications

Alessandra Iurlo

7 joint publications

Massimiliano Bonifacio

5 joint publications

Francesca Palandri

4 joint publications

Mario Tiribelli